Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
International Journal of Colorectal Disease|November 19, 2004
Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusionH T Arkenau, K Rettig, R PorschenBritish Journal of Cancer|December 9, 2010
Targeting BRAF for patients with melanomaH-T Arkenau, R Kefford, G V LongZeitschrift Fur Gastroenterologie|July 15, 2003
[Differential diagnosis of morbus Crohn disease: intussusception of the colon]H-T Arkenau, F Kruse, H H Jend, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trialH T Arkenau, A Bermann, K Rettig, et al.Zeitschrift Fur Gastroenterologie|August 10, 2005
Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literatureH-T Arkenau, O Müssig, T Buhr, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2009
Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer RegistryC L Ringland, H-T Arkenau, D L O'Connell, et al.Current Oncology (Toronto, Ont.)|March 7, 2018
Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA)M Uccello, M Moschetta, G Mak, et al.British Journal of Cancer|March 20, 2008
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experienceH-T Arkenau, D Olmos, J E Ang, et al.Zeitschrift Fur Gastroenterologie|November 19, 2002
Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulationH T Arkenau, D O Stichtenoth, J C Frölich, et al.British Journal of Cancer|September 17, 2002
Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trialO Nehls, B Klump, H T Arkenau, et al.Pageof 3